DSpace@İnönü

Yazar "Tabak, OF" için listeleme

Yazar "Tabak, OF" için listeleme

Sırala: Sıra: Sonuçlar:

  • Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine 
    Tanriover, MD; Doganay, HL; Akova, M; Guner, HR; Azap, A; Akhan, S; Kose, S; Erdinc, FS; Akalin, EH; Tabak, OF; Pullukcu, H; Batum, O; Yavuz, SS; Turhan, O; Yildirmak, MT; Koksal, I; Tasova, Y; Korten, V; Yilmaz, G; Celen, MK; Altin, S; Celik, I; Bayindir, Y; Karaoglan, I; Yilmaz, A; Ozkul, A; Gur, H; Unal, S (2021)
    Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral ...
  • Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine 
    Tanriover, MD; Doganay, HL; Akova, M; Guner, HR; Azap, A; Akhan, S; Kose, S; Erdinc, FS; Akalin, EH; Tabak, OF; Pullukcu, H; Batum, O; Yavuz, SS; Turhan, O; Yildirmak, MT; Koksal, I; Tasova, Y; Korten, V; Yilmaz, G; Celen, MK; Altin, S; Celik, I; Bayindir, Y; Karaoglan, I; Yilmaz, A; Ozkul, A; Gur, H; Unal, S (2021)
    Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral ...